Improvement of Visuo-spatial Function Assessed by Raven’s Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Donepezil is used to improve cognitive impairment of dementia with Lewy bodies (DLB). Visuo-spatial dysfunction is a well-known symptom of DLB. Non-verbal Raven’s Colored Progressive Matrices (RCPM) were used to assess both visual perception and reasoning ability in DLB subjects treated with donepezil. Methods: Twenty-one DLB patients (mean age, 78.7±4.5 years) were enrolled. RCPM assessment was performed at the time of starting donepezil and within one year after starting donepezil. Results: There were significant improvements of RCPM in the total scores between one year donepezil treatment (p=0.013), in both Set A score (p=0.002) and Set AB score (p=0.015), but trend in the Set B score (p=0.083). Conclusion: Donepezil is useful for improving visuo-spatial impairment in DLB, but not for problem-solving impairment
Abstract
Objective: Donepezil is used to improve cognitive impairment of dementia with Lewy bodies (DLB). Visuo-spatial dysfunction is a well-known symptom of DLB. Non-verbal Raven’s Colored Progressive Matrices (RCPM) were used to assess both visual perception and reasoning ability in DLB subjects treated with donepezil. Methods: Twenty-one DLB patients (mean age, 78.7±4.5 years) were enrolled. RCPM assessment was performed at the time of starting donepezil and within one year after starting donepezil. Results: There were significant improvements of RCPM in the total scores between one year donepezil treatment (p=0.013), in both Set A score (p=0.002) and Set AB score (p=0.015), but trend in the Set B score (p=0.083). Conclusion: Donepezil is useful for improving visuo-spatial impairment in DLB, but not for problem-solving impairment
참고문헌 (29)
- McKeith IG, "Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies(DLB) : report of the consortium on DLB international workshop", Neurology, 47, pp.1113~1124 (1996)
- McKeith IG, "Diagnosis and management of dementia with Lewy bodies : third report of the DLB Consortium", Neurology, 65, pp.1863~1872 (2005)
- Aarsland D, "A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia", Int J Geriatr Psychiatry, 16, pp.528~536 (2001)
- Galvin JE, "Lewy body dementia : caregiver burden and unmet needs", Alzheimer Dis Assoc Disord, pp.177~181 (2010)
- Mori E, "Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial", Ann Neurol, 72, pp.41~52 (2012)
- Matsunaga S, "Cholinesterase inhibitors for Lewy body disorders: a meta-analysis", Int J Neuropsychopharmacol, 19, pp.pyv086~ (2015)
- Thomas AJ, "A comparison of the efficacy of donepezil in Parkinson’s disease with dementia and dementia with Lewy bodies", Int J Geriatr Psychiatry, 20, pp.938~944 (2005)
- Mori E, "Visuoperceptual impairment in dementia with Lewy bodies", Arch Neurol, 57, pp.489~493 (2000)
- Mori T, "Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB", Neurology, 66, pp.935~937 (2006)
- Satoh M, "Improved visual hallucination by donepezil and occipital glucose metabolism in dementia with Lewy bodies : the Osaki-Tajiri project", Eur Neurol, 64, pp.337~344 (2010)
- Ala TA, "Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer’s disease", J Neurol Neurosurg Psychiatry, 70, pp.483~488 (2001)
- Collerton D, "Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia", Dement Geriatr Cogn Disord, 16, pp.229~237 (2003)
- Kimura F, "Acetylcholine suppresses the spread of excitation in the visual cortex revealed by optical recording : possible differential effect depending on the source of input", Eur J Neurosci, 11, pp.3597~3609 (1999)
- Silver MA, "Cholinergic enhancement reduces spatial spread of visual responses in human early visual cortex", Neuron, 60, pp.904~914 (2008)
- Raven JC, "Colored progressive matrices sets A, AB, B" (1947), H.K. Lewis
- Spreen O, "A compendium of neuropsychological tests: administration, norms, and commentary" (1998), Oxford University Press
- Kawai Y, "Neuropsychological differentiation between Alzheimer’s disease and dementia with Lewy bodies in a memory clinic", Psychogeriatrics, 13, pp.157~163 (2013)
- Folstein MF, "“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician", J Psychiatr Res, 12, pp.189~198 (1975)
- Cummings JL, "The Neuropsychiatric Inventory : comprehensive assessment of psychopathology in dementia", Neurology, 44, pp.2308~2314 (1994)
- Sugishita M, "Raven’s colored progressive matrices" (1993), Nihon Bunka Kagakusya
- Weichbold V, "Performance of hearing impaired children on Raven’s Coloured Progressive Matrices Test", Int J Pediatr Otorhinolaryngol, 67, pp.1213~1217 (2003)
- Ambra FI, "Qualitative patterns at Raven’s colored progressive matrices in mild cognitive impairment and Alzheimer’s disease", Aging Clin Exp Res, 28, pp.561~565 (2016)
- Saumier D, "Cognitive predictors of donepezil therapy response in Alzheimer disease", Dement Geriatr Cogn Disord, 24, pp.28~35 (2007)
- Soma S, "Cholinergic modulation of response gain in the rat primary visual cortex", Sci Rep, 3, pp.1138~ (2013)
- Cerami C, "Brain changes within the visuo-spatial attentional network in posterior cortical atrophy", J Alzheimers Dis, 43, pp.385~395 (2015)
- Shimada H, "Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET", Neurology, 73, pp.273~278 (2009)
- Tiraboschi P, "Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease", Arch Gen Psychiatry, 59, pp.946~951 (2002)
- Lee DR, "Assessment of cognitive fluctuation in dementia : a systematic review of the literature", Int J Geriatr Psychiatry, 27, pp.989~998 (2012)
- Ikeda M, "Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial", Alzheimers Res Ther, 7, pp.4~ (2015)